Low Gut Bacterial Richness Linked to Obesity
Individuals with low gut bacterial richness have more adiposity and a more pronounced inflammatory phenotype; and weight loss intervention can improve bacterial gene richness, according to two studies published in the Aug. 29 issue of Nature.
Read MoreNew Clinical Guidelines Issued for Esophageal Cancer
The Society of Thoracic Surgeons (STS) has released a set of clinical-practice guidelines to assist in the diagnosis and treatment of localized esophageal cancer. One of the key recommendations is that endoscopy with biopsy is the diagnostic test of choice for esophageal cancer. Another key …
Read MorePicnic Pathogens: Treating Foodborne Illness
An estimated 48 million cases of food poisoning occur annually in the United States that result in approximately 128,000 hospitalizations and 3,000 deaths. Foodborne illness can be caused by bacteria and viruses, parasites, mold, toxins, and contaminants, as well as allergens.
Read MoreOptimum Performance: Eating too much red meat could put you in danger zone
Red meat consumers take note: according to a recent study published in the Archive of Internal Medicine, “eating red meat is associated with a sharply increased risk of death from cancer and heart disease.”
Read MoreFDA Limits Duration, Usage of Tolvaptan Due to Possible Liver Injury
An increased risk of liver injury was observed in recent large clinical trials evaluating tolvaptan for a new use in patients with autosomal dominant polycystic kidney disease (ADPKD)
Read MorePrescribing Exercise Before and During Cancer Treatment May Lead to Better Outcomes
Prescribing an exercise regimen for patients with cancer prior to and during treatment may lead to a better quality of life and less fatigue, according to researchers at Henry Ford Hospital in Detroit, MI.
Read MoreAmitiza Approved for Opioid-Induced Constipation
Sucampo and Takeda announced that the FDA has approved the supplemental New Drug Application (sNDA) for Amitiza (lubiprostone) for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain.
Read MoreBydureon Warning for MTC and Acute Pancreatitis
The FDA has determined that a Risk Evaluation and Mitigation Strategy (REMS) is necessary to ensure that the benefits of Bydureon (exenatide extended-release for injectable suspension; Amylin) outweigh the potential risks including medullary thyroid carcinoma (MTC) and acute pancreatitis.
Read MoreGLP-1 Therapies Linked to Increased Pancreatitis
A recent study published in JAMA Internal Medicine concluded that treatment with the GLP-1 based therapies sitagliptin and exenatide in adults with type 2 diabetes mellitus was associated with increased odds of hospitalization for acute pancreatitis.
Read MoreReport Affirms Lifesaving Role of Colonoscopy
In patients tracked for as long as 20 years, the death rate from colorectal cancer was cut by 53 percent in those who had the test and whose doctors removed precancerous growths, known as adenomatous polyps, researchers reported on Wednesday in The New England Journal …
Read More